Human Solid Tumors: Cytogenetic Techniques
The field of cytogenetics has had a great impact on many aspects of medical and basic sciences, including clinical genetics and, perhaps most notably, hematology and oncology. Tumor cytogenetics has for many years been dedicated almost exclusively to the study of hematological malignancies, mainly because these are more readily accessible. Important information has been obtained: cytogenetic changes in tumors are acquired, clonal abnormalities that are specifically associated with pathological subtypes of malignancies and premalignant conditions; they have a clear prognostic impact, and are used for choice of treatment, patient stratification, and assessment of minimal disease. Furthermore, molecular investigations of recurrent cytogenetic changes have led to the discovery of genes that play a determining role in leukemia and oncogenesis in general.
- Analysis of Cancer Stem Cell Metastasis in Xenograft Animal Models
- Detecting Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma
- The Impact of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV): From Research to Clinical Practice
- Integrating Molecular Biomarkers into Current Clinical Management in Melanoma
- Static and Flow Cytometry
- Flow Cytometry Enumeration of Apoptotic Cancer Cells by Apoptotic Rate
- Parental Smoking and Childhood Leukemia
- Immune System Functional Pathway Analysis Using Single Cell Network Profiling (SCNP): A Novel Tool in Cancer Immunotherapy
- Detection of Telomerase Enzyme Activity by TRAP Assay
- Cell Migration and Invasion Assays